Global RNA-based Biopharmaceuticals Market Professional Survey Report 2017

Published Date : 2017-09-01

Published By : Qy Research Groups

Category : Pharma & Healthcare

No. of Pages : 110

This report studies RNA-based Biopharmaceuticals in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022.

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering
Pfizer
Roche
Sanofi-Aventis
Abbott Laboratories
Arrowhead Pharmaceuticals
Benitec Biopharma
Calimmune Inc
Dicerna
Gradalis
Quark
RXi
Senesco
Silence Therapeutics
Silenseed
Tekmira
Alnylam Pharmaceuticals

By types, the market can be split into
Therapeutics
Vaccines

By Application, the market can be split into
Cancer
Diabetes
Tuberculosis
Cardiovascular Diseases
Others

By Regions, this report covers (we can add the regions/countries as you want)
North America
China
Europe
Southeast Asia
Japan
India

If you have any special requirements, please let us know and we will offer you the report as you want.

Table of Contents

Global RNA-based Biopharmaceuticals Market Professional Survey Report 2017
1 Industry Overview of RNA-based Biopharmaceuticals
1.1 Definition and Specifications of RNA-based Biopharmaceuticals
1.1.1 Definition of RNA-based Biopharmaceuticals
1.1.2 Specifications of RNA-based Biopharmaceuticals
1.2 Classification of RNA-based Biopharmaceuticals
1.2.1 Therapeutics
1.2.2 Vaccines
1.3 Applications of RNA-based Biopharmaceuticals
1.3.1 Cancer
1.3.2 Diabetes
1.3.3 Tuberculosis
1.3.4 Cardiovascular Diseases
1.3.5 Others
1.4 Market Segment by Regions
1.4.1 North America
1.4.2 China
1.4.3 Europe
1.4.4 Southeast Asia
1.4.5 Japan
1.4.6 India

2 Manufacturing Cost Structure Analysis of RNA-based Biopharmaceuticals
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of RNA-based Biopharmaceuticals
2.3 Manufacturing Process Analysis of RNA-based Biopharmaceuticals
2.4 Industry Chain Structure of RNA-based Biopharmaceuticals

3 Technical Data and Manufacturing Plants Analysis of RNA-based Biopharmaceuticals
3.1 Capacity and Commercial Production Date of Global RNA-based Biopharmaceuticals Major Manufacturers in 2016
3.2 Manufacturing Plants Distribution of Global RNA-based Biopharmaceuticals Major Manufacturers in 2016
3.3 R&D Status and Technology Source of Global RNA-based Biopharmaceuticals Major Manufacturers in 2016
3.4 Raw Materials Sources Analysis of Global RNA-based Biopharmaceuticals Major Manufacturers in 2016

4 Global RNA-based Biopharmaceuticals Overall Market Overview
4.1 2012-2017E Overall Market Analysis
4.2 Capacity Analysis
4.2.1 2012-2017E Global RNA-based Biopharmaceuticals Capacity and Growth Rate Analysis
4.2.2 2016 RNA-based Biopharmaceuticals Capacity Analysis (Company Segment)
4.3 Sales Analysis
4.3.1 2012-2017E Global RNA-based Biopharmaceuticals Sales and Growth Rate Analysis
4.3.2 2016 RNA-based Biopharmaceuticals Sales Analysis (Company Segment)
4.4 Sales Price Analysis
4.4.1 2012-2017E Global RNA-based Biopharmaceuticals Sales Price
4.4.2 2016 RNA-based Biopharmaceuticals Sales Price Analysis (Company Segment)

5 RNA-based Biopharmaceuticals Regional Market Analysis
5.1 North America RNA-based Biopharmaceuticals Market Analysis
5.1.1 North America RNA-based Biopharmaceuticals Market Overview
5.1.2 North America 2012-2017E RNA-based Biopharmaceuticals Local Supply, Import, Export, Local Consumption Analysis
5.1.3 North America 2012-2017E RNA-based Biopharmaceuticals Sales Price Analysis
5.1.4 North America 2016 RNA-based Biopharmaceuticals Market Share Analysis
5.2 China RNA-based Biopharmaceuticals Market Analysis
5.2.1 China RNA-based Biopharmaceuticals Market Overview
5.2.2 China 2012-2017E RNA-based Biopharmaceuticals Local Supply, Import, Export, Local Consumption Analysis
5.2.3 China 2012-2017E RNA-based Biopharmaceuticals Sales Price Analysis
5.2.4 China 2016 RNA-based Biopharmaceuticals Market Share Analysis
5.3 Europe RNA-based Biopharmaceuticals Market Analysis
5.3.1 Europe RNA-based Biopharmaceuticals Market Overview
5.3.2 Europe 2012-2017E RNA-based Biopharmaceuticals Local Supply, Import, Export, Local Consumption Analysis
5.3.3 Europe 2012-2017E RNA-based Biopharmaceuticals Sales Price Analysis
5.3.4 Europe 2016 RNA-based Biopharmaceuticals Market Share Analysis
5.4 Southeast Asia RNA-based Biopharmaceuticals Market Analysis
5.4.1 Southeast Asia RNA-based Biopharmaceuticals Market Overview
5.4.2 Southeast Asia 2012-2017E RNA-based Biopharmaceuticals Local Supply, Import, Export, Local Consumption Analysis
5.4.3 Southeast Asia 2012-2017E RNA-based Biopharmaceuticals Sales Price Analysis
5.4.4 Southeast Asia 2016 RNA-based Biopharmaceuticals Market Share Analysis
5.5 Japan RNA-based Biopharmaceuticals Market Analysis
5.5.1 Japan RNA-based Biopharmaceuticals Market Overview
5.5.2 Japan 2012-2017E RNA-based Biopharmaceuticals Local Supply, Import, Export, Local Consumption Analysis
5.5.3 Japan 2012-2017E RNA-based Biopharmaceuticals Sales Price Analysis
5.5.4 Japan 2016 RNA-based Biopharmaceuticals Market Share Analysis
5.6 India RNA-based Biopharmaceuticals Market Analysis
5.6.1 India RNA-based Biopharmaceuticals Market Overview
5.6.2 India 2012-2017E RNA-based Biopharmaceuticals Local Supply, Import, Export, Local Consumption Analysis
5.6.3 India 2012-2017E RNA-based Biopharmaceuticals Sales Price Analysis
5.6.4 India 2016 RNA-based Biopharmaceuticals Market Share Analysis

6 Global 2012-2017E RNA-based Biopharmaceuticals Segment Market Analysis (by Type)
6.1 Global 2012-2017E RNA-based Biopharmaceuticals Sales by Type
6.2 Different Types of RNA-based Biopharmaceuticals Product Interview Price Analysis
6.3 Different Types of RNA-based Biopharmaceuticals Product Driving Factors Analysis
6.3.1 Therapeutics of RNA-based Biopharmaceuticals Growth Driving Factor Analysis
6.3.2 Vaccines of RNA-based Biopharmaceuticals Growth Driving Factor Analysis

7 Global 2012-2017E RNA-based Biopharmaceuticals Segment Market Analysis (by Application)
7.1 Global 2012-2017E RNA-based Biopharmaceuticals Consumption by Application
7.2 Different Application of RNA-based Biopharmaceuticals Product Interview Price Analysis
7.3 Different Application of RNA-based Biopharmaceuticals Product Driving Factors Analysis
7.3.1 Cancer of RNA-based Biopharmaceuticals Growth Driving Factor Analysis
7.3.2 Diabetes of RNA-based Biopharmaceuticals Growth Driving Factor Analysis
7.3.3 Tuberculosis of RNA-based Biopharmaceuticals Growth Driving Factor Analysis
7.3.4 Cardiovascular Diseases of RNA-based Biopharmaceuticals Growth Driving Factor Analysis
7.3.5 Others of RNA-based Biopharmaceuticals Growth Driving Factor Analysis

8 Major Manufacturers Analysis of RNA-based Biopharmaceuticals
8.1 Pfizer
8.1.1 Company Profile
8.1.2 Product Picture and Specifications
8.1.2.1 Product A
8.1.2.2 Product B
8.1.3 Pfizer 2016 RNA-based Biopharmaceuticals Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.1.4 Pfizer 2016 RNA-based Biopharmaceuticals Business Region Distribution Analysis
8.2 Roche
8.2.1 Company Profile
8.2.2 Product Picture and Specifications
8.2.2.1 Product A
8.2.2.2 Product B
8.2.3 Roche 2016 RNA-based Biopharmaceuticals Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.2.4 Roche 2016 RNA-based Biopharmaceuticals Business Region Distribution Analysis
8.3 Sanofi-Aventis
8.3.1 Company Profile
8.3.2 Product Picture and Specifications
8.3.2.1 Product A
8.3.2.2 Product B
8.3.3 Sanofi-Aventis 2016 RNA-based Biopharmaceuticals Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.3.4 Sanofi-Aventis 2016 RNA-based Biopharmaceuticals Business Region Distribution Analysis
8.4 Abbott Laboratories
8.4.1 Company Profile
8.4.2 Product Picture and Specifications
8.4.2.1 Product A
8.4.2.2 Product B
8.4.3 Abbott Laboratories 2016 RNA-based Biopharmaceuticals Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.4.4 Abbott Laboratories 2016 RNA-based Biopharmaceuticals Business Region Distribution Analysis
8.5 Arrowhead Pharmaceuticals
8.5.1 Company Profile
8.5.2 Product Picture and Specifications
8.5.2.1 Product A
8.5.2.2 Product B
8.5.3 Arrowhead Pharmaceuticals 2016 RNA-based Biopharmaceuticals Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.5.4 Arrowhead Pharmaceuticals 2016 RNA-based Biopharmaceuticals Business Region Distribution Analysis
8.6 Benitec Biopharma
8.6.1 Company Profile
8.6.2 Product Picture and Specifications
8.6.2.1 Product A
8.6.2.2 Product B
8.6.3 Benitec Biopharma 2016 RNA-based Biopharmaceuticals Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.6.4 Benitec Biopharma 2016 RNA-based Biopharmaceuticals Business Region Distribution Analysis
8.7 Calimmune Inc
8.7.1 Company Profile
8.7.2 Product Picture and Specifications
8.7.2.1 Product A
8.7.2.2 Product B
8.7.3 Calimmune Inc 2016 RNA-based Biopharmaceuticals Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.7.4 Calimmune Inc 2016 RNA-based Biopharmaceuticals Business Region Distribution Analysis
8.8 Dicerna
8.8.1 Company Profile
8.8.2 Product Picture and Specifications
8.8.2.1 Product A
8.8.2.2 Product B
8.8.3 Dicerna 2016 RNA-based Biopharmaceuticals Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.8.4 Dicerna 2016 RNA-based Biopharmaceuticals Business Region Distribution Analysis
8.9 Gradalis
8.9.1 Company Profile
8.9.2 Product Picture and Specifications
8.9.2.1 Product A
8.9.2.2 Product B
8.9.3 Gradalis 2016 RNA-based Biopharmaceuticals Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.9.4 Gradalis 2016 RNA-based Biopharmaceuticals Business Region Distribution Analysis
8.10 Quark
8.10.1 Company Profile
8.10.2 Product Picture and Specifications
8.10.2.1 Product A
8.10.2.2 Product B
8.10.3 Quark 2016 RNA-based Biopharmaceuticals Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.10.4 Quark 2016 RNA-based Biopharmaceuticals Business Region Distribution Analysis
8.11 RXi
8.12 Senesco
8.13 Silence Therapeutics
8.14 Silenseed
8.15 Tekmira
8.16 Alnylam Pharmaceuticals

9 Development Trend of Analysis of RNA-based Biopharmaceuticals Market
9.1 Global RNA-based Biopharmaceuticals Market Trend Analysis
9.1.1 Global 2017-2022 RNA-based Biopharmaceuticals Market Size (Volume and Value) Forecast
9.1.2 Global 2017-2022 RNA-based Biopharmaceuticals Sales Price Forecast
9.2 RNA-based Biopharmaceuticals Regional Market Trend
9.2.1 North America 2017-2022 RNA-based Biopharmaceuticals Consumption Forecast
9.2.2 China 2017-2022 RNA-based Biopharmaceuticals Consumption Forecast
9.2.3 Europe 2017-2022 RNA-based Biopharmaceuticals Consumption Forecast
9.2.4 Southeast Asia 2017-2022 RNA-based Biopharmaceuticals Consumption Forecast
9.2.5 Japan 2017-2022 RNA-based Biopharmaceuticals Consumption Forecast
9.2.6 India 2017-2022 RNA-based Biopharmaceuticals Consumption Forecast
9.3 RNA-based Biopharmaceuticals Market Trend (Product Type)
9.4 RNA-based Biopharmaceuticals Market Trend (Application)

10 RNA-based Biopharmaceuticals Marketing Type Analysis
10.1 RNA-based Biopharmaceuticals Regional Marketing Type Analysis
10.2 RNA-based Biopharmaceuticals International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of RNA-based Biopharmaceuticals by Region
10.4 RNA-based Biopharmaceuticals Supply Chain Analysis

11 Consumers Analysis of RNA-based Biopharmaceuticals
11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis


12 Conclusion of the Global RNA-based Biopharmaceuticals Market Professional Survey Report 2017
Methodology
Analyst Introduction
Data Source



List of Tables and Figures
Figure Picture of RNA-based Biopharmaceuticals
Table Product Specifications of RNA-based Biopharmaceuticals
Table Classification of RNA-based Biopharmaceuticals
Figure Global Production Market Share of RNA-based Biopharmaceuticals by Type in 2016
Figure Therapeutics Picture
Table Major Manufacturers of Therapeutics
Figure Vaccines Picture
Table Major Manufacturers of Vaccines
Table Applications of RNA-based Biopharmaceuticals
Figure Global Consumption Volume Market Share of RNA-based Biopharmaceuticals by Application in 2016
Figure Cancer Examples
Table Major Consumers in Cancer
Figure Diabetes Examples
Table Major Consumers in Diabetes
Figure Tuberculosis Examples
Table Major Consumers in Tuberculosis
Figure Cardiovascular Diseases Examples
Table Major Consumers in Cardiovascular Diseases
Figure Others Examples
Table Major Consumers in Others
Figure Market Share of RNA-based Biopharmaceuticals by Regions
Figure North America RNA-based Biopharmaceuticals Market Size (Million USD) (2012-2022)
Figure China RNA-based Biopharmaceuticals Market Size (Million USD) (2012-2022)
Figure Europe RNA-based Biopharmaceuticals Market Size (Million USD) (2012-2022)
Figure Southeast Asia RNA-based Biopharmaceuticals Market Size (Million USD) (2012-2022)
Figure Japan RNA-based Biopharmaceuticals Market Size (Million USD) (2012-2022)
Figure India RNA-based Biopharmaceuticals Market Size (Million USD) (2012-2022)
Table RNA-based Biopharmaceuticals Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of RNA-based Biopharmaceuticals in 2016
Figure Manufacturing Process Analysis of RNA-based Biopharmaceuticals
Figure Industry Chain Structure of RNA-based Biopharmaceuticals
Table Capacity and Commercial Production Date of Global RNA-based Biopharmaceuticals Major Manufacturers in 2016
Table Manufacturing Plants Distribution of Global RNA-based Biopharmaceuticals Major Manufacturers in 2016
Table R&D Status and Technology Source of Global RNA-based Biopharmaceuticals Major Manufacturers in 2016
Table Raw Materials Sources Analysis of Global RNA-based Biopharmaceuticals Major Manufacturers in 2016
Table Global Capacity, Sales , Price, Cost, Sales Revenue (M USD) and Gross Margin of RNA-based Biopharmaceuticals 2012-2017
Figure Global 2012-2017E RNA-based Biopharmaceuticals Market Size (Volume) and Growth Rate
Figure Global 2012-2017E RNA-based Biopharmaceuticals Market Size (Value) and Growth Rate
Table 2012-2017E Global RNA-based Biopharmaceuticals Capacity and Growth Rate
Table 2016 Global RNA-based Biopharmaceuticals Capacity (K Units) List (Company Segment)
Table 2012-2017E Global RNA-based Biopharmaceuticals Sales (K Units) and Growth Rate
Table 2016 Global RNA-based Biopharmaceuticals Sales (K Units) List (Company Segment)
Table 2012-2017E Global RNA-based Biopharmaceuticals Sales Price (USD/Unit)
Table 2016 Global RNA-based Biopharmaceuticals Sales Price (USD/Unit) List (Company Segment)
Figure North America Capacity Overview
Table North America Supply, Import, Export and Consumption (K Units) of RNA-based Biopharmaceuticals 2012-2017E
Figure North America 2012-2017E RNA-based Biopharmaceuticals Sales Price (USD/Unit)
Figure North America 2016 RNA-based Biopharmaceuticals Sales Market Share
Figure China Capacity Overview
Table China Supply, Import, Export and Consumption (K Units) of RNA-based Biopharmaceuticals 2012-2017E
Figure China 2012-2017E RNA-based Biopharmaceuticals Sales Price (USD/Unit)
Figure China 2016 RNA-based Biopharmaceuticals Sales Market Share
Figure Europe Capacity Overview
Table Europe Supply, Import, Export and Consumption (K Units) of RNA-based Biopharmaceuticals 2012-2017E
Figure Europe 2012-2017E RNA-based Biopharmaceuticals Sales Price (USD/Unit)
Figure Europe 2016 RNA-based Biopharmaceuticals Sales Market Share
Figure Southeast Asia Capacity Overview
Table Southeast Asia Supply, Import, Export and Consumption (K Units) of RNA-based Biopharmaceuticals 2012-2017E
Figure Southeast Asia 2012-2017E RNA-based Biopharmaceuticals Sales Price (USD/Unit)
Figure Southeast Asia 2016 RNA-based Biopharmaceuticals Sales Market Share
Figure Japan Capacity Overview
Table Japan Supply, Import, Export and Consumption (K Units) of RNA-based Biopharmaceuticals 2012-2017E
Figure Japan 2012-2017E RNA-based Biopharmaceuticals Sales Price (USD/Unit)
Figure Japan 2016 RNA-based Biopharmaceuticals Sales Market Share
Figure India Capacity Overview
Table India Supply, Import, Export and Consumption (K Units) of RNA-based Biopharmaceuticals 2012-2017E
Figure India 2012-2017E RNA-based Biopharmaceuticals Sales Price (USD/Unit)
Figure India 2016 RNA-based Biopharmaceuticals Sales Market Share
Table Global 2012-2017E RNA-based Biopharmaceuticals Sales (K Units) by Type
Table Different Types RNA-based Biopharmaceuticals Product Interview Price
Table Global 2012-2017E RNA-based Biopharmaceuticals Sales (K Units) by Application
Table Different Application RNA-based Biopharmaceuticals Product Interview Price
Table Pfizer Information List
Table Product A Overview
Table Product B Overview
Table 2016 Pfizer RNA-based Biopharmaceuticals Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Pfizer RNA-based Biopharmaceuticals Business Region Distribution
Table Roche Information List
Table Product A Overview
Table Product B Overview
Table 2016 Roche RNA-based Biopharmaceuticals Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Roche RNA-based Biopharmaceuticals Business Region Distribution
Table Sanofi-Aventis Information List
Table Product A Overview
Table Product B Overview
Table 2015 Sanofi-Aventis RNA-based Biopharmaceuticals Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Sanofi-Aventis RNA-based Biopharmaceuticals Business Region Distribution
Table Abbott Laboratories Information List
Table Product A Overview
Table Product B Overview
Table 2016 Abbott Laboratories RNA-based Biopharmaceuticals Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Abbott Laboratories RNA-based Biopharmaceuticals Business Region Distribution
Table Arrowhead Pharmaceuticals Information List
Table Product A Overview
Table Product B Overview
Table 2016 Arrowhead Pharmaceuticals RNA-based Biopharmaceuticals Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Arrowhead Pharmaceuticals RNA-based Biopharmaceuticals Business Region Distribution
Table Benitec Biopharma Information List
Table Product A Overview
Table Product B Overview
Table 2016 Benitec Biopharma RNA-based Biopharmaceuticals Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Benitec Biopharma RNA-based Biopharmaceuticals Business Region Distribution
Table Calimmune Inc Information List
Table Product A Overview
Table Product B Overview
Table 2016 Calimmune Inc RNA-based Biopharmaceuticals Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Calimmune Inc RNA-based Biopharmaceuticals Business Region Distribution
Table Dicerna Information List
Table Product A Overview
Table Product B Overview
Table 2016 Dicerna RNA-based Biopharmaceuticals Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Dicerna RNA-based Biopharmaceuticals Business Region Distribution
Table Gradalis Information List
Table Product A Overview
Table Product B Overview
Table 2016 Gradalis RNA-based Biopharmaceuticals Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Gradalis RNA-based Biopharmaceuticals Business Region Distribution
Table Quark Information List
Table Product A Overview
Table Product B Overview
Table 2016 Quark RNA-based Biopharmaceuticals Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Quark RNA-based Biopharmaceuticals Business Region Distribution
Table RXi Information List
Table Senesco Information List
Table Silence Therapeutics Information List
Table Silenseed Information List
Table Tekmira Information List
Table Alnylam Pharmaceuticals Information List
Figure Global 2017-2022 RNA-based Biopharmaceuticals Market Size (K Units) and Growth Rate Forecast
Figure Global 2017-2022 RNA-based Biopharmaceuticals Market Size (Million USD) and Growth Rate Forecast
Figure Global 2017-2022 RNA-based Biopharmaceuticals Sales Price (USD/Unit) Forecast
Figure North America 2017-2022 RNA-based Biopharmaceuticals Consumption Volume (K Units) and Growth Rate Forecast
Figure China 2017-2022 RNA-based Biopharmaceuticals Consumption Volume (K Units) and Growth Rate Forecast
Figure Europe 2017-2022 RNA-based Biopharmaceuticals Consumption Volume (K Units) and Growth Rate Forecast
Figure Southeast Asia 2017-2022 RNA-based Biopharmaceuticals Consumption Volume (K Units) and Growth Rate Forecast
Figure Japan 2017-2022 RNA-based Biopharmaceuticals Consumption Volume (K Units) and Growth Rate Forecast
Figure India 2017-2022 RNA-based Biopharmaceuticals Consumption Volume (K Units) and Growth Rate Forecast
Table Global Sales Volume (K Units) of RNA-based Biopharmaceuticals by Type 2017-2022
Table Global Consumption Volume (K Units) of RNA-based Biopharmaceuticals by Application 2017-2022
Table Traders or Distributors with Contact Information of RNA-based Biopharmaceuticals by Region

Research Assistance Research Assistance

We will be happy to help you find what you need. Please write to us:

+1-888-236-2744

sales@qyresearchgroups.com